Paul Wycliffe

Paul Wycliffe is an experienced executive in the biopharmaceutical industry, currently serving as Vice President of Sales at AmbioPharm, a prominent peptide contract development and manufacturing organization, since June 2024. Previously, Paul held various leadership roles, including Vice President of Business Development at Pharmaron and Senior Director of Commercial Development at FUJIFILM Diosynth Biotechnologies. Additional experience includes positions as Global Key Account Manager at Lonza and Pharma Business Manager at QIAGEN. Paul began a research career as a post-doctoral fellow at the University of Michigan, focusing on virology and immunology. Paul holds a PhD in Cell and Molecular Biology from the Swedish University of Agricultural Sciences and a Master’s degree in Zoology from The American College.